Accelerating Advanced Pharmaceutical Synthesis With Strong Non-Nucleophilic Bases
In modern pharmaceutical process chemistry and active pharmaceutical ingredient (API) manufacturing, carrying out selective deprotonation reactions on sensitive organic molecules without inducing unwanted nucleophilic additions or ester hydrolyses is fundamental to success. Complex drug candidates—such as targeted oncology therapeutics, antiviral molecules, and complex macrolide...
0 Yorumlar 0 hisse senetleri 84 Views 0 önizleme